The FAP Gene Support Group

(Familial Adenomatous Polyposis)

Homepage About us Trials Menu Worldwide Trial Desmoid Trial Curcumin
Comparison of Trials Curcumin Personal Trial Curcumin Research Curcumin Suppliers More studies on Curcumin Disclaimer

The FAP Gene Support Group

is pleased to promote the following trial

For patients with desmoid tumors or aggressive fibromatosis - Alliance A091105:

A Phase III, Double Blind, Randomized, Placebo-Controlled Trial of Sorafenib in Desmoid Tumors or Aggressive Fibromatosis (DT/DF).

Patient Brochure PDF File

Further Information and FAQ's PDF File

The Alliance for Clinical Trials in Oncology (Alliance), which is one of the five National Cancer Institute sponsored cooperative research groups in the United States, conducting large multicenter trials in oncology.

Relevant to sarcoma, we have recently launched trial for patients with desmoid tumors or aggressive fibromatosis - Alliance A091105: A Phase III, Double Blind, Randomized, Placebo-Controlled Trial of Sorafenib in Desmoid Tumors or Aggressive Fibromatosis (DT/DF).

This pivotal trial addresses a very rare population, with less than 1.000 cases per year, according to NCI Surveillance, Epidemiology, and End Results (SEER) Program databases. There are limited therapies available for desmoid tumors. More research into the disease is needed for a possible cause and potential treatment.

For more information, contact the National Cancer Institute Cancer Information Service toll-free at 1 -800-422-6237 or visit their website at www.cancer.gov. You can also visit the Alliance website at www.AllianceforClinicalTrialsinOncology.org.